234 related articles for article (PubMed ID: 29676599)
1. Psoriasis in pregnancy: case series and literature review of data concerning exposure during pregnancy to ustekinumab.
Galluzzo M; D'Adamio S; Bianchi L; Talamonti M
J Dermatolog Treat; 2019 Feb; 30(1):40-44. PubMed ID: 29676599
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy during Ustekinumab Treatment for Severe Psoriasis.
Rocha K; Piccinin MC; Kalache LF; Reichert-Faria A; Silva de Castro CC
Dermatology; 2015; 231(2):103-4. PubMed ID: 25790947
[TBL] [Abstract][Full Text] [Related]
3. Use of TNF-inhibitors and ustekinumab for psoriasis during pregnancy: A patient series.
Lund T; Thomsen SF
Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28071837
[TBL] [Abstract][Full Text] [Related]
4. Treatment of severe psoriasis with ustekinumab during pregnancy.
Andrulonis R; Ferris LK
J Drugs Dermatol; 2012 Oct; 11(10):1240. PubMed ID: 23134993
[TBL] [Abstract][Full Text] [Related]
5. A Case Series of Patients With Psoriasis Exposed to Biologic Therapy During Pregnancy: The BIOBADADERM Register and a Review of the Literature.
Echeverría-García B; Nuño-González A; Dauden E; Vanaclocha F; Torrado R; Belinchón I; Pérez-Zafrilla B;
Actas Dermosifiliogr; 2017 Mar; 108(2):168-170. PubMed ID: 27765165
[No Abstract] [Full Text] [Related]
6. Management of moderate to severe plaque psoriasis in pregnancy and lactation in the era of biologics.
Mervic L
Acta Dermatovenerol Alp Pannonica Adriat; 2014; 23(2):27-31. PubMed ID: 24964946
[TBL] [Abstract][Full Text] [Related]
7. Biologics exposure during pregnancy and breastfeeding in a psoriasis patient.
Mugheddu C; Atzori L; Lappi A; Murgia S; Rongioletti F
Dermatol Ther; 2019 May; 32(3):e12895. PubMed ID: 30958637
[TBL] [Abstract][Full Text] [Related]
8. Survival rates of biological therapies for psoriasis treatment in real-world clinical practice: A Canadian multicentre retrospective study.
Marinas JE; Kim WB; Shahbaz A; Qiang JK; Greaves S; Yeung J
Australas J Dermatol; 2018 Feb; 59(1):e11-e14. PubMed ID: 27858976
[TBL] [Abstract][Full Text] [Related]
9. Biological therapies for psoriasis: Adherence and outcome analysis from a clinical perspective.
Ross C; Marshman G; Grillo M; Stanford T
Australas J Dermatol; 2016 May; 57(2):137-40. PubMed ID: 25754697
[TBL] [Abstract][Full Text] [Related]
10. Drug Survival of Biological Therapies for Psoriasis Treatment in Germany and Associated Costs: A Retrospective Claims Database Analysis.
Mahlich J; Alba A; Hadad LE; Leisten MK; Peitsch WK
Adv Ther; 2019 Jul; 36(7):1684-1699. PubMed ID: 31102203
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials.
Reich K; Burden AD; Eaton JN; Hawkins NS
Br J Dermatol; 2012 Jan; 166(1):179-88. PubMed ID: 21910698
[TBL] [Abstract][Full Text] [Related]
12. Current biological therapies for use in HIV-positive patients with psoriasis: case report of gesulkumab used and review.
Bartos G; Cline A; Beroukhim K; Burrall BA; Feldman SR
Dermatol Online J; 2018 Nov; 24(11):. PubMed ID: 30695971
[TBL] [Abstract][Full Text] [Related]
13. Psoriasis in those planning a family, pregnant or breast-feeding. The Australasian Psoriasis Collaboration.
Rademaker M; Agnew K; Andrews M; Armour K; Baker C; Foley P; Frew J; Gebauer K; Gupta M; Kennedy D; Marshman G; Sullivan J
Australas J Dermatol; 2018 May; 59(2):86-100. PubMed ID: 28543445
[TBL] [Abstract][Full Text] [Related]
14. Reversible Posterior Leukoencephalopathy Syndrome (RPLS) in a Psoriasis Patient Treated With Ustekinumab.
Dickson L; Menter A
J Drugs Dermatol; 2017 Feb; 16(2):177-179. PubMed ID: 28300862
[TBL] [Abstract][Full Text] [Related]
15. Satisfaction and Awareness of Systemic Psoriasis Treatments: A National Survey Comparing Biologic and Nonbiologic Users.
Ighani A; Yu AM; Sandhu VK; Barankin B; Manolson MF
J Cutan Med Surg; 2019; 23(2):148-156. PubMed ID: 30801221
[TBL] [Abstract][Full Text] [Related]
16. Ustekinumab in Real-Life Practice: Experience in 116 Patients with Moderate-To-Severe Psoriasis.
Raposo I; Bettencourt A; Leite L; Selores M; Torres T
Acta Med Port; 2019 Mar; 32(3):214-218. PubMed ID: 30946793
[TBL] [Abstract][Full Text] [Related]
17. Inadvertent pregnancy during ustekinumab therapy in a patient with plaque psoriasis and impetigo herpetiformis.
Alsenaid A; Prinz JC
J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):488-90. PubMed ID: 25413895
[No Abstract] [Full Text] [Related]
18. Switching biologics in severe pediatric psoriasis: a retrospective analysis.
Ramos Pinheiro R; Diamantino F; Cabete J; Brasileiro A; Baptista J; Lopes MJP
Int J Dermatol; 2017 Dec; 56(12):1461-1464. PubMed ID: 28960270
[No Abstract] [Full Text] [Related]
19. Long persistence of tumour necrosis factor-α antagonist-induced autoantibodies under subsequent treatment with ustekinumab but no adverse effects: a case study of 14 patients with psoriasis.
Hoffmann JHO; Knoop C; Enk AH; Hadaschik EN
Br J Dermatol; 2018 Jan; 178(1):e9-e10. PubMed ID: 28581119
[No Abstract] [Full Text] [Related]
20. Increase in antinuclear antibody levels through biologic treatment for psoriasis.
Miki M; Endo C; Naka Y; Fukuya Y; Kobayashi S; Kawashima M; Tsunemi Y
J Dermatol; 2019 Feb; 46(2):e50-e51. PubMed ID: 30051919
[No Abstract] [Full Text] [Related]
[Next] [New Search]
